CN Stock MarketDetailed Quotes

300357 Zhejiang Wolwo Bio-Pharmaceutical

Watchlist
  • 24.11
  • -0.78-3.13%
Market Closed Nov 14 15:00 CST
12.62BMarket Cap40.45P/E (TTM)

Zhejiang Wolwo Bio-Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
8.38%730.24M
11.12%429.26M
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
Operating revenue
8.38%730.24M
11.12%429.26M
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
Other operating revenue
----
770.36%2.19M
----
554.82%7.44M
----
-55.85%251.51K
----
-68.23%1.14M
----
-40.00%569.7K
Total operating cost
14.36%427.57M
15.08%265.41M
19.37%132.39M
5.48%513.94M
5.30%373.88M
9.67%230.62M
2.59%110.91M
11.25%487.24M
13.44%355.06M
9.08%210.29M
Operating cost
11.86%34.63M
11.33%21.69M
8.24%10.42M
-2.64%40.19M
1.14%30.96M
17.93%19.48M
17.47%9.62M
19.86%41.28M
20.07%30.61M
9.55%16.52M
Operating tax surcharges
46.07%4.66M
61.87%3.5M
47.54%1.29M
26.96%5.76M
2.71%3.19M
11.74%2.16M
12.34%876.35K
19.98%4.53M
17.16%3.1M
14.22%1.94M
Operating expense
11.61%270.79M
10.96%163.44M
16.25%80.96M
3.64%323.17M
6.42%242.62M
9.48%147.29M
3.85%69.64M
10.53%311.81M
10.95%227.99M
6.33%134.54M
Administration expense
29.84%52.76M
28.30%33.65M
28.53%16.46M
29.87%62.11M
17.02%40.63M
28.36%26.23M
17.56%12.8M
-7.78%47.82M
-1.49%34.72M
-7.31%20.43M
Financial expense
-5.07%-23.14M
-14.08%-16.12M
-13.23%-7.3M
-21.70%-29.48M
-24.46%-22.02M
-19.77%-14.13M
-13.77%-6.45M
-9.37%-24.23M
-5.31%-17.69M
-4.29%-11.8M
-Interest expense (Financial expense)
-1.76%899.57K
-5.94%619.42K
19.02%319.26K
194.70%1.31M
267.75%915.71K
354.48%658.57K
235.20%268.23K
22.57%443.98K
-9.31%249.01K
-25.62%144.91K
-Interest Income (Financial expense)
-5.22%-24.23M
-13.86%-16.9M
-15.15%-7.76M
-24.96%-30.96M
-27.77%-23.03M
-23.74%-14.85M
-16.68%-6.74M
-9.42%-24.77M
-4.99%-18.03M
-3.72%-12M
Research and development
11.93%87.86M
19.48%59.25M
25.19%30.56M
5.83%112.2M
2.85%78.49M
1.90%49.59M
-9.08%24.41M
20.58%106.02M
25.31%76.32M
25.60%48.67M
Credit Impairment Loss
-66.87%-4.92M
-3,268.01%-2.47M
-2,967.77%-1.88M
169.98%903.31K
29.13%-2.95M
109.20%78.07K
109.88%65.63K
19.07%-1.29M
2.75%-4.16M
54.71%-848.48K
Asset Impairment Loss
----
----
----
98.94%-472.55K
---472.55K
---472.55K
----
---44.4M
----
----
Other net revenue
1,896.57%13.51M
112.55%8.59M
79.17%4.15M
185.28%10.72M
-97.83%676.75K
-85.79%4.04M
-85.05%2.31M
-154.23%-12.57M
155.46%31.25M
121.35%28.42M
Fair value change income
51.47%-763.41K
102.49%30.18K
140.75%400.18K
24.25%-666.94K
-251.92%-1.57M
-272.34%-1.21M
-149.61%-982.13K
-783.37%-880.46K
-73.21%1.04M
-115.66%-325.52K
Invest income
174.43%6.48M
-101.65%-53.11K
-114.74%-363.77K
-46.56%1.91M
-49.43%2.36M
-34.17%3.21M
265.97%2.47M
-44.03%3.58M
193.09%4.67M
186.04%4.88M
-Including: Investment income associates
204.81%3.99M
46.00%-1.05M
44.73%-434.53K
14.06%-4.25M
-49.08%-3.8M
-65.60%-1.94M
-158.53%-786.13K
-159.16%-4.95M
-1,044.38%-2.55M
---1.17M
Asset deal income
--568.93K
--353.47K
--284.61K
----
----
----
----
---271.92K
---271.92K
---271.92K
Other revenue
266.98%12.15M
341.07%10.73M
649.12%5.71M
-70.54%9.04M
-88.96%3.31M
-90.27%2.43M
-94.46%761.72K
66.12%30.7M
171.22%29.98M
128.65%24.99M
Operating profit
5.19%316.18M
7.97%172.43M
18.06%88.01M
-12.93%344.97M
-20.14%300.59M
-22.86%159.71M
-28.97%74.54M
0.84%396.21M
18.00%376.37M
23.48%207.03M
Add:Non operating Income
-66.39%354.57K
-76.22%235.09K
-25.58%117.42K
-35.02%1.78M
-52.61%1.06M
-44.11%988.72K
-87.35%157.78K
340.72%2.74M
-9.93%2.23M
-9.16%1.77M
Less:Non operating expense
1,565.30%3.01M
2,058.31%2.17M
5,587.52%327.4K
306.44%795.74K
113.03%180.72K
27.60%100.62K
-92.70%5.76K
-62.96%195.78K
-81.74%84.83K
-9.97%78.85K
Total profit
4.00%313.52M
6.16%170.5M
17.54%87.8M
-13.24%345.96M
-20.36%301.46M
-23.06%160.6M
-29.61%74.7M
1.46%398.75M
17.93%378.52M
23.12%208.72M
Less:Income tax cost
22.42%51.03M
47.60%27.88M
80.84%13.88M
-19.98%50.43M
-30.06%41.68M
-41.85%18.89M
-55.25%7.67M
-5.53%63.02M
9.01%59.6M
18.41%32.48M
Net profit
1.05%262.5M
0.64%142.62M
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
Net profit from continuing operation
1.05%262.5M
0.64%142.62M
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
Less:Minority Profit
5.89%-9.76M
4.11%-6.61M
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
Net profit of parent company owners
0.78%272.25M
0.42%149.23M
9.55%77.21M
-11.06%310.18M
-17.44%270.15M
-17.93%148.6M
-23.17%70.48M
3.19%348.77M
19.16%327.22M
22.92%181.08M
Earning per share
Basic earning per share
0.78%0.52
0.42%0.285
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
Diluted earning per share
0.78%0.52
0.42%0.285
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
Other composite income
-117.52%-1.42K
56,115.18%5.38M
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
Other composite income of parent company owners
-117.52%-1.42K
56,115.18%5.38M
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
Total composite income
1.04%262.5M
4.43%148M
18.28%79.26M
-11.98%295.53M
-18.55%259.79M
-19.59%141.72M
-24.67%67.01M
-4.68%335.75M
19.77%318.95M
24.04%176.26M
Total composite income of parent company owners
0.78%272.25M
4.03%154.61M
17.15%82.56M
-11.07%310.19M
-17.45%270.16M
-17.94%148.61M
-23.18%70.47M
-4.16%348.8M
19.18%327.25M
22.93%181.09M
Total composite income of minority owners
5.89%-9.76M
4.11%-6.61M
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 8.38%730.24M11.12%429.26M18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M
Operating revenue 8.38%730.24M11.12%429.26M18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M
Other operating revenue ----770.36%2.19M----554.82%7.44M-----55.85%251.51K-----68.23%1.14M-----40.00%569.7K
Total operating cost 14.36%427.57M15.08%265.41M19.37%132.39M5.48%513.94M5.30%373.88M9.67%230.62M2.59%110.91M11.25%487.24M13.44%355.06M9.08%210.29M
Operating cost 11.86%34.63M11.33%21.69M8.24%10.42M-2.64%40.19M1.14%30.96M17.93%19.48M17.47%9.62M19.86%41.28M20.07%30.61M9.55%16.52M
Operating tax surcharges 46.07%4.66M61.87%3.5M47.54%1.29M26.96%5.76M2.71%3.19M11.74%2.16M12.34%876.35K19.98%4.53M17.16%3.1M14.22%1.94M
Operating expense 11.61%270.79M10.96%163.44M16.25%80.96M3.64%323.17M6.42%242.62M9.48%147.29M3.85%69.64M10.53%311.81M10.95%227.99M6.33%134.54M
Administration expense 29.84%52.76M28.30%33.65M28.53%16.46M29.87%62.11M17.02%40.63M28.36%26.23M17.56%12.8M-7.78%47.82M-1.49%34.72M-7.31%20.43M
Financial expense -5.07%-23.14M-14.08%-16.12M-13.23%-7.3M-21.70%-29.48M-24.46%-22.02M-19.77%-14.13M-13.77%-6.45M-9.37%-24.23M-5.31%-17.69M-4.29%-11.8M
-Interest expense (Financial expense) -1.76%899.57K-5.94%619.42K19.02%319.26K194.70%1.31M267.75%915.71K354.48%658.57K235.20%268.23K22.57%443.98K-9.31%249.01K-25.62%144.91K
-Interest Income (Financial expense) -5.22%-24.23M-13.86%-16.9M-15.15%-7.76M-24.96%-30.96M-27.77%-23.03M-23.74%-14.85M-16.68%-6.74M-9.42%-24.77M-4.99%-18.03M-3.72%-12M
Research and development 11.93%87.86M19.48%59.25M25.19%30.56M5.83%112.2M2.85%78.49M1.90%49.59M-9.08%24.41M20.58%106.02M25.31%76.32M25.60%48.67M
Credit Impairment Loss -66.87%-4.92M-3,268.01%-2.47M-2,967.77%-1.88M169.98%903.31K29.13%-2.95M109.20%78.07K109.88%65.63K19.07%-1.29M2.75%-4.16M54.71%-848.48K
Asset Impairment Loss ------------98.94%-472.55K---472.55K---472.55K-------44.4M--------
Other net revenue 1,896.57%13.51M112.55%8.59M79.17%4.15M185.28%10.72M-97.83%676.75K-85.79%4.04M-85.05%2.31M-154.23%-12.57M155.46%31.25M121.35%28.42M
Fair value change income 51.47%-763.41K102.49%30.18K140.75%400.18K24.25%-666.94K-251.92%-1.57M-272.34%-1.21M-149.61%-982.13K-783.37%-880.46K-73.21%1.04M-115.66%-325.52K
Invest income 174.43%6.48M-101.65%-53.11K-114.74%-363.77K-46.56%1.91M-49.43%2.36M-34.17%3.21M265.97%2.47M-44.03%3.58M193.09%4.67M186.04%4.88M
-Including: Investment income associates 204.81%3.99M46.00%-1.05M44.73%-434.53K14.06%-4.25M-49.08%-3.8M-65.60%-1.94M-158.53%-786.13K-159.16%-4.95M-1,044.38%-2.55M---1.17M
Asset deal income --568.93K--353.47K--284.61K-------------------271.92K---271.92K---271.92K
Other revenue 266.98%12.15M341.07%10.73M649.12%5.71M-70.54%9.04M-88.96%3.31M-90.27%2.43M-94.46%761.72K66.12%30.7M171.22%29.98M128.65%24.99M
Operating profit 5.19%316.18M7.97%172.43M18.06%88.01M-12.93%344.97M-20.14%300.59M-22.86%159.71M-28.97%74.54M0.84%396.21M18.00%376.37M23.48%207.03M
Add:Non operating Income -66.39%354.57K-76.22%235.09K-25.58%117.42K-35.02%1.78M-52.61%1.06M-44.11%988.72K-87.35%157.78K340.72%2.74M-9.93%2.23M-9.16%1.77M
Less:Non operating expense 1,565.30%3.01M2,058.31%2.17M5,587.52%327.4K306.44%795.74K113.03%180.72K27.60%100.62K-92.70%5.76K-62.96%195.78K-81.74%84.83K-9.97%78.85K
Total profit 4.00%313.52M6.16%170.5M17.54%87.8M-13.24%345.96M-20.36%301.46M-23.06%160.6M-29.61%74.7M1.46%398.75M17.93%378.52M23.12%208.72M
Less:Income tax cost 22.42%51.03M47.60%27.88M80.84%13.88M-19.98%50.43M-30.06%41.68M-41.85%18.89M-55.25%7.67M-5.53%63.02M9.01%59.6M18.41%32.48M
Net profit 1.05%262.5M0.64%142.62M10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M
Net profit from continuing operation 1.05%262.5M0.64%142.62M10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M
Less:Minority Profit 5.89%-9.76M4.11%-6.61M4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M
Net profit of parent company owners 0.78%272.25M0.42%149.23M9.55%77.21M-11.06%310.18M-17.44%270.15M-17.93%148.6M-23.17%70.48M3.19%348.77M19.16%327.22M22.92%181.08M
Earning per share
Basic earning per share 0.78%0.520.42%0.2859.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.3458
Diluted earning per share 0.78%0.520.42%0.2859.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.3458
Other composite income -117.52%-1.42K56,115.18%5.38M89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K
Other composite income of parent company owners -117.52%-1.42K56,115.18%5.38M89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K
Total composite income 1.04%262.5M4.43%148M18.28%79.26M-11.98%295.53M-18.55%259.79M-19.59%141.72M-24.67%67.01M-4.68%335.75M19.77%318.95M24.04%176.26M
Total composite income of parent company owners 0.78%272.25M4.03%154.61M17.15%82.56M-11.07%310.19M-17.45%270.16M-17.94%148.61M-23.18%70.47M-4.16%348.8M19.18%327.25M22.93%181.09M
Total composite income of minority owners 5.89%-9.76M4.11%-6.61M4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data